CRBU Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill - Mentions: QURE TCRX PHIO MTC ...

Gapping stocks in Monday's session

3 days ago - By: Chartmill - Mentions: DD TGE QURE TCRX ...

Discover the top movers in Monday's pre-market session.

2 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in Upcoming Investor Conferences

2 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in Upcoming Investor Conferences

3 days ago - By: Benzinga

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today?

3 days ago - By: Stocktwits - Mentions: VXF CNCR

Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments

3 days ago - By: Benzinga - Mentions: IMRN CUE LQDA TCRX ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

3 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

3 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

3 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

3 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

3 days ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

2 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

2 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

3 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Bragar Eagel & Squire

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

5 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

5 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

6 months ago - By: Zacks Investment Research - Mentions: CTMX

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

6 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

6 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

6 months ago - By: Zacks Investment Research - Mentions: CLSD

Will Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know

6 months ago - By: Zacks Investment Research - Mentions: AMGN

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

7 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

7 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

8 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

8 months ago - By: Caribou Biosciences, Inc.

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

8 months ago - By: Bragar Eagel & Squire

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

8 months ago - By: THE ROSEN LAW FIRM, P. A.

CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit

8 months ago - By: The Gross Law Firm

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

9 months ago - By: Levi & Korsinsky, LLP

February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBU

9 months ago - By: Faruqi & Faruqi, LLP

Faruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU

9 months ago - By: The Gross Law Firm

Caribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU

9 months ago - By: THE ROSEN LAW FIRM, P. A.

CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit

9 months ago - By: The Rosen Law Firm PA

CRBU DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action - CRBU

CARIBOU BIOSCIENCES INC (CRBU) Stock News

CRBU Latest News, Press Relases and Analysis